Patent Armory, Inc. v. Align Technology, Inc.: Voluntary Dismissal With Prejudice in Wireless 3D Shape Sensing Patent Dispute

📄 View Full Report 📥 Export PDF 🔗 Share ⭐ Save

In a swift resolution lasting just 85 days, Patent Armory, Inc. voluntarily dismissed with prejudice all patent infringement claims against Align Technology, Inc. in the Delaware District Court (Case No. 1:24-cv-00605). Filed on May 21, 2024, and closed on August 14, 2024, the case centered on U.S. Patent No. 7,256,899 B1, covering wireless methods and systems for three-dimensional non-contact shape sensing — technology directly relevant to Align Technology’s flagship clear aligner and intraoral scanning business. The dismissal was executed under Federal Rule of Civil Procedure 41(a)(1)(A)(i), with each party bearing its own costs, expenses, and attorneys’ fees.

For IP strategists and patent counsel, voluntary dismissals with prejudice filed this early — before the defendant even entered an appearance or filed responsive pleadings — frequently signal either a pre-litigation settlement, a licensing resolution, or a strategic retreat following rapid due diligence on claim strength. This case warrants close attention from in-house IP teams operating in the dental diagnostics, intraoral scanning, and 3D non-contact measurement spaces, as it signals active assertion of wireless shape-sensing patents against major medtech incumbents.

📋 Case Summary

Case Name Patent Armory, Inc. v. Align Technology Inc.
Case Number1:24-cv-00605
Court Delaware District Court
Duration May 21, 2024 – August 14, 2024 85 days
Outcome Dismissed with Prejudice
Patents at Issue
Products InvolvedWireless methods and systems for three-dimensional non-contact shape sensing
Verdict CauseInfringement Action
Chief JudgeColm F. Connolly

Case Overview

The Parties

⚖️ Plaintiff

Patent Armory, Inc. is a non-practicing entity (patent assertion entity) that acquires and enforces patents across technology domains. In this case, Patent Armory acted as the asserting party, asserting U.S. Patent 7,256,899 B1 related to wireless 3D non-contact shape sensing against a major dental technology company.

🛡️ Defendant

Align Technology, Inc. is a leading global medical device company best known for the Invisalign clear aligner system and iTero intraoral scanners, holding a dominant position in the digital orthodontics and dental diagnostics market. Align was named as the accused infringer based on its wireless and 3D scanning technologies used in dental treatment planning.

The Patent at Issue

U.S. Patent No. 7,256,899 B1 covers wireless methods and systems for performing three-dimensional, non-contact shape sensing — that is, capturing the precise geometry of physical objects without physically touching them, using wireless data transmission. In practical application, this technology is relevant to intraoral 3D scanners that digitally map teeth and gum structures, as well as industrial and medical non-contact measurement tools. The patent’s claims focus on the wireless communication architecture enabling remote or untethered capture and transmission of 3D shape data.

🔍

Building wireless 3D scanning or sensing systems?

Run a freedom-to-operate search against U.S. 7,256,899 and related wireless shape-sensing patents before your next product launch to identify infringement risk early.

Run FTO Check →

Legal Representation

Plaintiff Counsel: Garibian Law Offices, PC (lead: Antranig N. Garibian)

Litigation Timeline & Procedural History

MilestoneDate
Case FiledMay 21, 2024
CourtDelaware District Court
Chief JudgeColm F. Connolly
Case ClosedAugust 14, 2024
Total Duration85 days (85 days)
Basis of TerminationDismissed with Prejudice

The case was filed in the District of Delaware, the nation’s most active patent litigation venue, which remains the jurisdiction of choice for patent assertion entities targeting large technology and medical device companies. Filed at the first-instance district court level before Chief Judge Colm F. Connolly — a jurist known for rigorous standing and disclosure requirements for patent plaintiffs, particularly NPEs — the choice of venue likely reflects both convenience for Align Technology’s registered presence and standard PAE filing strategy.

At just 85 days from filing to closure, this case resolved at an unusually early stage. The plaintiff invoked Rule 41(a)(1)(A)(i), which permits a plaintiff to dismiss without a court order before the defendant serves an answer or a motion for summary judgment — indicating Align Technology had not yet formally responded to the complaint. This procedural posture strongly suggests the parties reached a rapid out-of-court resolution, potentially a licensing agreement or covenant not to sue, or that Patent Armory assessed the litigation risk unfavorably following Align’s likely pre-answer communications. The mutual cost-bearing provision is consistent with a negotiated exit rather than a pure capitulation.

The Verdict & Legal Analysis

Outcome

The case was dismissed with prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i), meaning Patent Armory, Inc. voluntarily and unilaterally initiated the dismissal before Align Technology filed any responsive pleading. No damages were awarded, no injunctive relief was granted, and no validity or infringement findings were made on the merits. Each party was ordered to bear its own costs, expenses, and attorneys’ fees, precluding any fee-shifting under 35 U.S.C. § 285.

Verdict Cause Analysis

The following factors illuminate the legal and strategic dynamics underlying this early voluntary dismissal with prejudice:

  • Rule 41(a)(1)(A)(i) dismissals require no court approval and are available only before the defendant serves an answer or summary judgment motion, suggesting Align Technology had not yet formally appeared — an extraordinarily early resolution.
  • The ‘with prejudice’ designation permanently bars Patent Armory from re-asserting the same claims of U.S. 7,256,899 against Align Technology, indicating the resolution was final and likely involved some form of consideration or covenant.
  • The mutual cost-bearing provision departs from a pure unilateral retreat and implies a negotiated arrangement, as prevailing defendants in PAE cases sometimes seek fee awards under 35 U.S.C. § 285 or Rule 11 when plaintiffs dismiss early.
  • Chief Judge Connolly’s court has established standing disclosure requirements for patent plaintiffs, including identification of all entities with financial interest in the litigation, which may have accelerated settlement timelines for NPE plaintiffs in his courtroom.

Legal Significance

  1. 1. This dismissal produces no claim construction record, no invalidity findings, and no infringement rulings, meaning U.S. Patent 7,256,899 B1 remains fully enforceable and can be asserted against other defendants in the intraoral scanning and 3D sensing market.
  2. 2. The case underscores the strategic importance of Chief Judge Connolly’s standing and disclosure orders in Delaware, which have materially affected NPE litigation timelines and may be contributing to earlier resolutions in patent cases before his court.
  3. 3. Companies in the dental technology, industrial metrology, and wireless sensing sectors should treat this dismissal not as a clean bill of health for the patent, but as a signal that Patent Armory continues to actively monetize shape-sensing IP and may pursue other targets.

Strategic Takeaways

For Patent Attorneys:

  • When defending against early-stage NPE complaints in Judge Connolly’s Delaware court, leverage his standing disclosure requirements proactively — early demands for full ownership and funding disclosure can accelerate settlement negotiations or expose procedural vulnerabilities.
  • The Rule 41(a)(1)(A)(i) exit here occurred before any responsive pleading, so counsel for similarly situated defendants should consider rapid pre-answer outreach and licensing discussions as a cost-effective first response to PAE complaints.
  • Because the dismissal is with prejudice and no claim construction occurred, the patent’s scope remains unlitigated — attorneys advising other companies in the 3D scanning space should conduct independent claim construction analysis of U.S. 7,256,899 to assess exposure.
  • Monitor Patent Armory’s filing history for subsequent suits asserting U.S. 7,256,899 against other defendants in medtech or industrial sensing, as serial assertion campaigns often follow early settlements with anchor defendants.

For IP Professionals:

  • In-house IP teams at dental technology, intraoral scanning, and 3D metrology companies should immediately add U.S. Patent 7,256,899 B1 to their patent watch lists and assess product-level FTO exposure, particularly for wireless data transmission components in 3D sensing workflows.
  • The mutual cost-bearing outcome and short case duration suggest a possible licensing resolution — in-house counsel should proactively audit existing licenses and freedom-to-operate opinions covering wireless shape-sensing patents to ensure they are current and litigation-ready.

For R&D Teams:

  • Engineering teams developing wireless intraoral scanners, handheld 3D measurement devices, or non-contact sensing systems should conduct a design-around analysis of U.S. 7,256,899’s claims, particularly those covering wireless data capture and transmission architecture.
  • Documenting prior art and technical differentiation from the claimed wireless 3D sensing methods in U.S. 7,256,899 should be a near-term R&D priority for product teams in dental diagnostics and industrial metrology, as this patent remains active and asserted.
⚠️

Freedom to Operate (FTO) Analysis & Implications

This case has significant FTO implications. Choose your next step:

📋 Understand This Case’s Implications

Learn how this ruling impacts patentability standards and your competitive landscape.

  • Monitor post-ruling developments
  • Identify trends in this technology area
  • Access comprehensive legal analysis and precedents
📊 View Legal Precedents
⚠️
High Risk Area

Wireless three-dimensional non-contact shape sensing systems

📋
Active PAE Assertion Risk

U.S. 7,256,899 B1 remains enforceable with no invalidity or non-infringement findings on the merits, creating ongoing assertion risk for companies in the intraoral scanning and 3D sensing markets.

Early Licensing Strategy

The rapid resolution here suggests proactive pre-litigation engagement with Patent Armory may yield favorable licensing terms before costly district court proceedings begin.

✅ Key Takeaways

For Patent Attorneys & Litigators

U.S. Patent 7,256,899 B1 has never been adjudicated on the merits and remains a live litigation risk — conduct independent claim mapping against your client’s wireless 3D sensing products before any demand letter arrives.

Search US7256899 claim history →

Rule 41(a)(1)(A)(i) dismissals in Judge Connolly’s court are increasingly common in NPE cases — understanding his standing disclosure orders is essential for both plaintiff and defense counsel in Delaware patent litigation.

View Judge Connolly case history →

The with-prejudice dismissal forecloses re-assertion against Align Technology but leaves the patent fully available against other defendants — monitor Patent Armory’s docket for follow-on complaints in this technology area.

Track Patent Armory filings →

Fee-shifting under 35 U.S.C. § 285 was not triggered here, but defendants facing similar early PAE suits should preserve all procedural grounds for an ‘exceptional case’ finding to maximize settlement leverage.

Research § 285 fee award cases →
For IP Professionals

Add U.S. 7,256,899 to your patent landscape monitoring immediately — its continued enforceability and Patent Armory’s demonstrated willingness to assert it against a market leader like Align Technology signals broader industry exposure.

Monitor wireless sensing patents →

Review your company’s FTO opinions covering wireless 3D scanning and non-contact measurement systems — opinions predating this litigation may not account for Patent Armory’s current claim interpretation and assertion theory.

Review FTO analysis tools →
🔒
Unlock R&D Team Recommendations
Get actionable patent strategy steps for product teams, including FTO timing and risk management guidance.
FTO Timing Guidance Design-Around Strategies Risk Management
Explore Full Analysis in PatSnap Eureka

Frequently Asked Questions

Ready to Strengthen Your Patent Strategy?

Join 18,000+ IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyse competitive landscapes with AI-powered precision.

PatSnap IP Intelligence Team

Patent Research & Competitive Intelligence · PatSnap

This analysis was produced by the PatSnap IP Intelligence Team — a group of patent analysts, IP strategists, and data scientists who work daily with PatSnap’s global patent database of over 2 billion structured data points across patents, litigation records, scientific literature, and regulatory filings.

The team specialises in tracking landmark litigation outcomes, translating complex court rulings into actionable IP strategy, and identifying the competitive intelligence implications for R&D and legal teams. All case analysis is grounded in primary sources: official court records, USPTO filings, and Federal Circuit opinions.

📊 2B+ Patent Data Points 🌍 120+ Countries Covered 🏢 18,000+ Customers Worldwide ⚖️ Global Litigation Database 🔍 Primary Source Verified
⚖️ Disclaimer: This article is for informational purposes only and does not constitute legal advice. The analysis presented reflects publicly available case information and general legal principles. For specific advice regarding patent litigation, FTO analysis, or IP strategy, please consult a qualified patent attorney.